Clinical Trials Browser

Phase 1/2 × NIH × Zoledronic Acid × Clear all

NCT00588913 2013-07-10

Adoptive Immunotherapy, Aldesleukin, and Zoledronate in Treating Patients With Stage IV Kidney Cancer and Lung Metastases

Phase 1/2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms, Neoplasm Metastasis